首页> 外文期刊>Brazilian Journal of Infectious Diseases >A pharmacodynamic strategy to optimize empirical antibiotic therapy for gram-negative bacteria in a Brazilian Intensive Care Unit
【24h】

A pharmacodynamic strategy to optimize empirical antibiotic therapy for gram-negative bacteria in a Brazilian Intensive Care Unit

机译:在巴西重症监护病房优化革兰氏阴性细菌经验性抗生素治疗的药效学策略

获取原文
获取外文期刊封面目录资料

摘要

Pharmacodynamic analyses were proposed to determine optimal empirical antibiotic therapy against Gram-negative bacteria isolated in a Brazilian ICU. Due to high resistance rates, standard regimens of cefepime, ciprofloxacin, meropenem, and piperacillin/tazobactam were not able to attain significant bactericidal CFR. Prolonged infusion of meropenem achieved 88% CFR, making it a possible empirical regimen in this ICU until susceptibilities become available. Still, even through administration of high dose prolonged infusions, 12.0% of simulated subjects did not achieve bactericidal exposure, suggesting that combination therapy would frequently be required in this setting. In conclusion, we recommend that in the presence of identified resistance problems among Gram-negative bacteria in a unit or hospital, MIC testing of formulary agents should be conducted along with pharmacodynamic simulation to assist in choosing an optimal antibiotic and dosage regimen for empirical use of severe infections until cultures and susceptibilities become available.
机译:提出了药效学分析,以确定针对巴西ICU中分离的革兰氏阴性细菌的最佳经验性抗生素治疗。由于高耐药率,头孢吡肟,环丙沙星,美洛培南和哌拉西林/他唑巴坦的标准治疗方案无法实现显着的杀菌CFR。长期输注美洛培南可达到88%的病死率,这使得该ICU可能有经验性治疗方案,直到有易感性为止。尽管如此,即使通过大剂量长时间输注给药,仍有12.0%的模拟受试者未达到杀菌暴露水平,这表明在这种情况下经常需要联合治疗。总之,我们建议,如果在单位或医院中革兰氏阴性菌中存在确定的耐药性问题,则应对配方药物进行MIC测试以及药效学模拟,以协助选择最佳的抗生素和剂量方案,以进行经验性使用。严重感染,直到获得培养物和敏感性为止。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号